Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1995
03/09/1995WO1995006415A1 Senescent cell-derived inhibitors of dna synthesis
03/09/1995WO1995006411A1 Method and composition for weight reduction
03/09/1995WO1995006407A1 Novel component of amyloid in alzheimer's disease and methods for use of same
03/09/1995CA2170979A1 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta
03/09/1995CA2170901A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995CA2170777A1 Epiligrin, an epithelial ligand for integrins
03/09/1995CA2170751A1 Neuron regulatory factor for promoting neuron survival
03/09/1995CA2170727A1 Methods and compositions for binding tau and map2c proteins
03/09/1995CA2170726A1 Bacterial exported proteins and acellular vaccines based thereon
03/09/1995CA2170395A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars
03/09/1995CA2170393A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995CA2170390A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995CA2170148A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis
03/09/1995CA2169951A1 Monoclonal antibody that recognizes interstitial cell surface antigen
03/09/1995CA2169950A1 Monoclonal antibody that induces apoptosis
03/09/1995CA2169557A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995CA2168565A1 T cell epitopes of ryegrass pollen allergen
03/09/1995CA2158934A1 Methods of suppressing immune response by gene therapy
03/09/1995CA2158933A1 Methods of suppressing graft rejection
03/09/1995CA2158932A1 Methods of suppressing autoimmune response
03/09/1995CA2131639A1 Thioglycerol derivatives
03/09/1995CA2131512A1 Nutritional supplement
03/08/1995EP0641858A1 Serum calcium depressing factor
03/08/1995EP0641800A1 Lactol derivatives as inhibiters of cathepsin L
03/08/1995EP0641776A2 Thioglycerol derivatives
03/08/1995EP0641567A1 Stable pharmaceutical compositions containing hybrid alpha-interferon
03/08/1995EP0641562A1 Nutritional supplement
03/08/1995EP0641385A1 Development of dna probes and immunological reagents of human tumor associated antigens
03/08/1995EP0641359A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
03/08/1995EP0641358A1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
03/08/1995EP0641325A1 Retroviral protease inhibitors
03/08/1995EP0641236A1 A method for coated particles in a spray-drying plant.
03/08/1995EP0641223A1 Biotherapeutic cell-coated microspheres
03/08/1995EP0641220A1 Methods and agents for modulating immune response, and uses thereof
03/08/1995EP0641218A1 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
03/08/1995EP0641217A1 Amylase-electrolyte oral rehydration method and apparatus
03/08/1995EP0641215A1 Protease-resistant thrombomodulin analogs
03/08/1995EP0641214A1 Non-bitter protein hydrolyzates
03/08/1995EP0641212A1 Method and reagent for inhibiting cancer development
03/08/1995EP0641193A1 Chemotherapeutic drug combinations
03/08/1995EP0502876B1 New blood-clot-dissolving proteins, and their preparation from the leech hirudo medicinalis
03/08/1995EP0500641B1 Control of milk secretion
03/08/1995EP0495013B1 Hexapeptides with sulphate ester groups
03/08/1995EP0487562B1 Pharmaceutical compositions
03/08/1995EP0466769B1 Reducing post-prandial plasma large neutral amino acid concentrations
03/08/1995CN1099802A Tumor necrosis factor muteins
03/08/1995CN1099801A Peptides
03/08/1995CN1099760A Cyclic adhesion inhibitors
03/08/1995CN1099759A 哌嗪衍生物 Piperazine derivatives
03/08/1995CA2131587A1 Method for regulation of nf-kb
03/07/1995US5395929 Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
03/07/1995US5395923 Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
03/07/1995US5395825 Medical diagnosis of infertility in females
03/07/1995US5395824 Dipeptide derivative and prophylactic and therapeutic agent for bone diseases containing the same
03/07/1995US5395823 Neuropeptide Y agonists and partial agonists
03/07/1995US5395822 Use of pyruvate to prevent neuronal degeneration associated with ischemia
03/07/1995US5395760 Isolated dna sequence encoding selected amino acid sequences
03/07/1995US5395753 Method for diagnosing rheumatoid arthritis
03/07/1995US5395613 Process for degradation of keratin, keratinaceous material, collagen and collagenaceous material with enzyme material, cell-free culture or cell culture from micrococcus sedentarius
03/07/1995US5395612 Limiting nitric oxide production to restore vascular contractile sensitivity
03/07/1995CA1334655C De-mannosyl teicoplanin derivatives
03/07/1995CA1334652C Histamine release inhibitory factor and preparations thereof
03/04/1995CA2131430A1 Microsomal triglyceride transfer protein
03/04/1995CA2131397A1 Lactol derivatives, their production and use
03/04/1995CA2105528A1 Heparin component for the treatment of neutrophil elastase-mediated damages, in particular associated with cystic fibrosis
03/02/1995WO1995006247A1 Natural killer cell-specific antigen and antibodies that identify the same
03/02/1995WO1995006131A1 A method for the assay, prophylaxis and/or treatment of human disease conditions
03/02/1995WO1995006125A1 CHIMERIC RECEPTOR CONTAINING ONE IgG BINDING DOMAIN OF BOTH PROTEIN A AND PROTEIN G
03/02/1995WO1995006122A2 Recombinant alternaria alternata allergenes
03/02/1995WO1995006121A2 Recombinant cladosporium herbarum allergens
03/02/1995WO1995006120A1 Recombinant cells from the monocyte-macrophage cell line for gene therapy
03/02/1995WO1995006119A1 Recombinant humanized anti-human immunodeficiency virus antibody
03/02/1995WO1995006118A1 Expression control sequences of the p-selectin gene
03/02/1995WO1995006117A1 Human 5-ht2 receptor
03/02/1995WO1995006077A2 Polymeric matrices and their uses in pharmaceutical compositions
03/02/1995WO1995006067A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
03/02/1995WO1995006065A1 Cytokines that bind the cell surface receptor hek
03/02/1995WO1995006064A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i
03/02/1995WO1995006063A1 Factor for fibroblast colony forming unit
03/02/1995WO1995006061A1 Retroviral protease inhibitors and combinations thereof
03/02/1995WO1995006060A1 Peptide compound
03/02/1995WO1995006055A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
03/02/1995WO1995006031A1 Inhibitors of tnf-alpha secretion
03/02/1995WO1995006030A1 Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
03/02/1995WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
03/02/1995WO1995005852A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections
03/02/1995WO1995005851A1 HIV vif-RELATED COMPOSITIONS, AND PROPHYLACTIC AND THERAPEUTIC USES THEREOF
03/02/1995WO1995005850A1 Campylobacter jejuni antigens, and methods for their production and use
03/02/1995WO1995005848A1 Protracted glp-1
03/02/1995WO1995005847A1 Accessory factor function for interferon gamma and its receptor
03/02/1995WO1995005846A1 Neural regeneration using human bone morphogenetic proteins
03/02/1995WO1995005845A1 Pharmaceutical formulations of nerve growth factor
03/02/1995WO1995005844A1 Method for the prevention and treatment of bovine mastitis
03/02/1995WO1995005843A1 Method for producing a highly enriched population of hematopoietic stem cells
03/02/1995WO1995005842A1 Method and device for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
03/02/1995WO1995005841A1 Novel tripeptides useful in immune and cns therapy
03/02/1995WO1995005840A1 Periodontal disease remedy
03/02/1995WO1995005835A1 Gene therapy for solid tumors, papillomas and warts
03/02/1995WO1995005833A1 Pharmaceutical composition for immunoenhancement therapy
03/02/1995WO1995005813A1 COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID
1 ... 2857 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 2874 2875 2876 2877 ... 3163